Researcher
Piet Maes
- Disciplines:Microbiology, Systems biology, Laboratory medicine
Affiliations
- Laboratory of Clinical and Epidemiological Virology (Rega Institute) (Division)
Member
From1 Jan 2002 → Today
Projects
1 - 10 of 23
- New AntiVirals for Infections with Pandemic PotentialFrom1 Jan 2024 → TodayFunding: HORIZON.2.1 - Health
- Integrating Multi-Disciplinary Expertise in a Learning and Adaptive European Pandemic Preparedness SystemFrom1 Oct 2023 → TodayFunding: HORIZON.2.1 - Health
- Correlates of Immunity to filovirus infectionFrom19 Sep 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Discovery and in-depth characterization of paramyxovirusesFrom1 Nov 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Exploration of unknown viruses in Belgian ticksFrom5 Oct 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- The construction of biologically contained filovirus systems and their purposes in antiviral compound screening and receptor binding associated studies.From18 Jan 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- PhD on the epidemiology of invasive pneumococcal diseaseFrom25 Oct 2021 → TodayFunding: BOF - doctoral mandates
- Characterizing the virus diversity in Belgian and European batsFrom1 Oct 2021 → 30 Sep 2022Funding: BOF - postdoctoral mandates
- Dynamics of cytomegalovirus infection: evolution towards antiviral drug resistanceFrom1 Feb 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Unraveling of protective innate and adaptive immune responses to SARS-CoV-2 in the setting of HCoV crossreactivityFrom1 Jan 2021 → 31 Dec 2022Funding: IOF - technology validation in lab
Publications
31 - 40 of 214
- Imprinted antibody responses against SARS-CoV-2 Omicron sublineages(2022)
Authors: Rana Abdelnabi, Piet Maes, Johan Neyts
Pages: 619 - + - Updated vaccine protects against SARS-CoV-2 variants including Omicron (B.1.1.529) and prevents transmission in hamsters(2022)
Authors: Sapna Sharma, Winnie Kerstens, Madina Rasulova, Rana Abdelnabi, Viktor Lemmens, Piet Maes, Guy Baele, Birgit Weynand, Philippe Lemey, Johan Neyts, et al.
- Development and optimization of biologically contained Marburg virus for high-throughput antiviral screening(2022)
Authors: Bert Vanmechelen, Lieve Naesens, Kurt Vermeire, Piet Maes
- Exhaled breath SARS-CoV-2 shedding patterns across variants of concern(2022)
Authors: Jos Feys, Elisabeth Marchal, Piet Maes, Emmanuel Andre
Pages: 25 - 33 - Two Years of Genomic Surveillance in Belgium during the SARS-CoV-2 Pandemic to Attain Country-Wide Coverage and Monitor the Introduction and Spread of Emerging Variants(2022)
Authors: Lize Cuypers, Simon Dellicour, Sam Hong, Piet Maes, Emmanuel Andre, Guy Baele
- Genomic evidence of co-identification with Omicron and Delta SARS-CoV-2 variants: a report of two cases(2022)
Authors: Lize Cuypers, Emmanuel Andre, Guy Baele, Piet Maes
Pages: 212 - 214 - The role of airborne transmission in a large single source outbreak of SARS-CoV-2 in a Belgian nursing home in 2020(2022)
Authors: Lize Cuypers, Guy Baele, Emmanuel Andre, Piet Maes
- Potent neutralizing anti-SARS-CoV-2 human antibodies cure infection with SARS-CoV-2 variants in hamster model(2022)
Authors: Maya Imbrechts, Wim Maes, Louanne Ampofo, Nathalie Van den Berghe, Bas Calcoen, Winnie Kerstens, Madina Rasulova, Sam Noppen, Rana Abdelnabi, Piet Maes, et al.
- Characterization of Emerging Serotype 19A Pneumococcal Strains in Invasive Disease and Carriage, Belgium(2022)
Authors: Stefanie Desmet, Lies Laenen, Lize Cuypers, Piet Maes, Wouter Bossuyt
Pages: 1606 - 1614 - In search of viable SARS-CoV-2 in the tear film: a prospective clinical study in hospitalized symptomatic patients(2022)
Authors: Heleen Delbeke, Stefanie Desmet, Piet Maes, Ingele Casteels
Pages: 1172 - 1173